Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MLLT4 Antisense RNA 1 (Head To Head) (MLLT4-AS1) (Middle Region) Peptid

MLLT4-AS1 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN2184949
  • Target Alle MLLT4-AS1 Produkte
    MLLT4-AS1 (MLLT4 Antisense RNA 1 (Head To Head) (MLLT4-AS1))
    Protein Region
    Middle Region
    Spezies
    Human
    Quelle
    • 1
    Synthetic
    Applikation
    Blocking Peptide (BP), Western Blotting (WB)
    Sequenz
    WTGGAGSKWG CSAGSGRAVL GPNGRWVPWA VLGSVRTGGA GSKWAALGPM
    Produktmerkmale
    This is a synthetic peptide designed for use in combination with anti-MLLT4-AS1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
    Aufreinigung
    Purified
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Konzentration
    1 mg/mL
    Buffer
    Final peptide concentration is 1 mg/mL in PBS.
    Handhabung
    Avoid repeat freeze-thaw cycles.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target
    MLLT4-AS1 (MLLT4 Antisense RNA 1 (Head To Head) (MLLT4-AS1))
    Synonyme
    AFDN-AS1 Peptide, C6orf124 Peptide, HGC6.4 Peptide, MLLT4-AS1 Peptide, dJ431P23.3 Peptide, AFDN divergent transcript Peptide, AFDN-DT Peptide
    Substanzklasse
    Antibody
    Hintergrund
    The function of this protein remains unknown.

    Alias Symbols: C6orf124, HGC6.4, dJ431P23.3

    Protein Size: 254
    Molekulargewicht
    25 kDa
    Gen-ID
    653483
    NCBI Accession
    NM_001042508, NP_001035973
    UniProt
    Q9Y6Z5
Sie sind hier:
Kundenservice